Literature DB >> 12893611

The impact of rubella immunization on the serological status of women of childbearing age: a retrospective longitudinal study in Melbourne, Australia.

Barbara H Francis1, Adrian K Thomas, Catherine A McCarty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12893611      PMCID： PMC1447953          DOI： 10.2105/ajph.93.8.1274

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  11 in total

1.  Congenital rubella in the Asian community in Britain.

Authors:  E Miller; P Waight; S A Rousseau; M H Hambling; P Rushton; D Ellis; G Jones
Journal:  BMJ       Date:  1990-12-15

2.  Rubella--could do better.

Authors:  J E Banatvala
Journal:  Lancet       Date:  1998-03-21       Impact factor: 79.321

3.  Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-11-24       Impact factor: 17.586

4.  The epidemiology of rubella and congenital rubella in Australia, 1992 to 1997.

Authors:  E M Sullivan; M A Burgess; J M Forrest
Journal:  Commun Dis Intell       Date:  1999-08-05

5.  The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention.

Authors:  Susan E Reef; Teryl K Frey; Katherine Theall; Emily Abernathy; Cindy L Burnett; Joseph Icenogle; Mary Mason McCauley; Melinda Wharton
Journal:  JAMA       Date:  2002 Jan 23-30       Impact factor: 56.272

6.  Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella.

Authors:  T C Heath; M A Burgess; J M Forrest
Journal:  Commun Dis Intell       Date:  1998-08-06

7.  Mumps and rubella eliminated from Finland.

Authors:  H Peltola; I Davidkin; M Paunio; M Valle; P Leinikki; O P Heinonen
Journal:  JAMA       Date:  2000 Nov 22-29       Impact factor: 56.272

8.  Congenital rubella syndrome: a risk in immigrant populations.

Authors:  E Sheridan; C Aitken; D Jeffries; M Hird; P Thayalasekaran
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

9.  The impact of rubella immunisation on the incidence of rubella, congenital rubella syndrome and rubella-related terminations of pregnancy in South Australia.

Authors:  T Cheffins; A Chan; R J Keane; E A Haan; R Hall
Journal:  Br J Obstet Gynaecol       Date:  1998-09

10.  Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme.

Authors:  E Miller; P Tookey; P Morgan-Capner; L Hesketh; D Brown; P Waight; J Vurdien; G Jones; C Peckham
Journal:  Commun Dis Rep CDR Rev       Date:  1994-11-11
View more
  10 in total

1.  Evaluation of three immunoassays used for detection of anti-rubella virus immunoglobulin M antibodies.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Joan Marler; Nicolas Laven; Susan Leeson; Elizabeth M Dax
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

2.  Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Barbara Francis; Nicholas Laven; Joan Marler; David Dickeson; Tony Panayotou; Kim Wilson; Robyn Wootten; Elizabeth M Dax
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

3.  Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays.

Authors:  Wayne Dimech; Nilukshi Arachchi; Jingjing Cai; Terri Sahin; Kim Wilson
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

4.  Assessing Immunity to Rubella Virus: a Plea for Standardization of IgG (Immuno)assays.

Authors:  Elise Bouthry; Milena Furione; Daniela Huzly; Adaeze Ogee-Nwankwo; LiJuan Hao; Adebola Adebayo; Joseph Icenogle; Antonella Sarasini; Maria Grazia Revello; Liliane Grangeot-Keros; Christelle Vauloup-Fellous
Journal:  J Clin Microbiol       Date:  2016-05-04       Impact factor: 5.948

5.  Where to Now for Standardization of Anti-Rubella Virus IgG Testing.

Authors:  Wayne Dimech
Journal:  J Clin Microbiol       Date:  2016-05-11       Impact factor: 5.948

6.  Rubella immunity among pregnant women in a Canadian provincial screening program.

Authors:  Mark J Kearns; Sabrina S Plitt; Bonita E Lee; Joan L Robinson
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

Review 7.  Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies.

Authors:  Wayne Dimech; Liliane Grangeot-Keros; Christelle Vauloup-Fellous
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

8.  Humoral immune response to primary rubella virus infection.

Authors:  Kim M Wilson; Carlie Di Camillo; Larissa Doughty; Elizabeth M Dax
Journal:  Clin Vaccine Immunol       Date:  2006-03

9.  Parity status and the relationship between antenatal rubella serology with obstetric outcome.

Authors:  Terence T Lao; Shuk Yi Annie Hui; Daljit S Sahota
Journal:  Sci Rep       Date:  2022-01-24       Impact factor: 4.379

10.  Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger.

Authors:  Shuk Yi Annie Hui; Daljit S Sahota; Terence T Lao
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.